Search the Newsreel

Nutex Health: A 'Strong Buy' Amid Margin Expansion, Regulatory Tailwinds (Upgrade) (NUTX)

¿Podrá Nutanix (NTNX) mantenerse por debajo de su valor razonable a pesar de sus buenos resultados?

Can Nutanix (NTNX) Stay Below Fair Value With Rich Earnings?

Nutanix’s Secure AI Automation Push Might Change The Case For Investing In Nutanix (NTNX)

In August 2026, Nutanix launched an open-source Model Context Protocol (MCP) server for its Cloud Platform, allowing AI assistants like GitHub Copilot, Claude Code, and Cursor to safely translate plain-English requests into governed infrastructure actions via the Nutanix Prism v4 API. By embedding fine-grained …

Is Nutrien’s Strong Q2, Higher Potash Guidance And Buyback Altering The Investment Case For Nutrien (TSX:NTR)?

Nutrien Ltd. recently reported second-quarter 2026 results, with sales of US$10,812 million and net income of US$1,214 million, and declared a US$0.55 per-share quarterly dividend payable on October 16, 2026, to shareholders of record on September 29, 2026. The company also completed a US$261 …

Nutrien Ltd. $NTR Shares Sold by Cardinal Capital Management Inc.

Nutrien (TSX:NTR) Could Be 16% Undervalued After Mixed Quarter And Higher Potash Outlook

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Nutrien's mixed quarter and updated outlook Nutrien (TSX:NTR) reported second quarter sales that were higher than expected, supported by stronger potash prices even as volumes …

Nutrien (TSX:NTR) Stock May Be 36% Undervalued On Cash Flow

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Nutrien stock has delivered a 44.5% total return over the past five years, and …

How Nutrien Ltd. (NTR) Affects Rotational Strategy Timing

This article from Stock Traders Daily analyzes Nutrien Ltd. (NTR) using AI models to provide trading strategies for different risk profiles. Key findings indicate neutral near and mid-term readings but a positive long-term bias, with an exceptional risk-reward setup targeting an 11.2% gain. It …

Nutrien Ltd. Price Target Cut to $74.00/Share From $76.00 by National Bank

National Bank has adjusted its price target for Nutrien Ltd. (NYSE:NTR) to $74.00 per share, down from the previous target of $76.00. This revision comes after the company's Q2 earnings report, which indicated a slight earnings per share beat but a miss on revenue …

Nutex Health (NASDAQ:NUTX) Trading Down 5.5% - Here's What Happened

Nutex Health (NASDAQ:NUTX) shares traded down 5.5% on Tuesday, closing at $186.62 with a significant 86% decrease in trading volume. Despite the drop, analyst sentiment remains positive with a "Moderate Buy" consensus and an average price target of $268.33. Institutional investment in Nutex Health …

Kriti Nutrients Q1FY27 net profit falls 1.6% to ₹9.06 crore

Nutrien's Q2 Earnings Lag, Revenues Beat Estimates on Higher Prices

Nutrien Ltd. NTR reported net earnings of $1.22 billion or $2.53 per share for the second quarter of 2026. This compares with net earnings of $1.23 billion or $2.50 per share in the year-ago quarter. Barring one-time items, adjusted earnings were $2.61 per share, …

Nutex Health (NUTX) Is Up 29.2% After Swinging From Loss To Q2 Profitability - What's Changed

Nutex Health Inc. (NUTX) reported a significant improvement in its Q2 2026 financial results, swinging from a net loss to a net income of US$65.84 million, despite a decline in revenue. This shift has led to a 29.2% increase in its stock price and …

Will Burcon NutraScience Corporation (BU) Beat Earnings Estimates in Its Next Report?

Australian Dairy Nutritionals (ASX:AHF) Rises As Leadership Reset Meets Funding Support

Nutex Health jumps 21%, continuing post-earnings run (NUTX:NASDAQ)

Nutex Health (NUTX) shares surged nearly 21% on Monday, extending a previous 7% gain after the company's second-quarter earnings release. The stock's recent performance is attributed to strong Q2 earnings, significant net income improvement, and cost reductions, despite a revenue miss. The company's earnings …

Nutrien Ltd. stock rises Monday, outperforms market

Nutrien Ltd. (NTR) stock increased by 2.77% on Monday, closing at C$92.38 and outperforming the broader Canadian market. The S&P/TSX Composite Index rose by 0.21%. Despite the rise, Nutrien Ltd. shares are still 21.0% below their 52-week high reached in March.

Nutex Health Q2 Profit Soars As IDR Cost Reductions Drive Margin Gains

(RTTNews) - Shares of Nutex Health Inc. (NUTX) are up 14.88% today. The company recently reported its second-quarter 2026 financial results, with investors focusing on a sharp improvement in profitability, stronger hospital visit volumes, favorable IDR-related cost reductions and continued operating cash generation. Nutex …

Betting its financial growth on next gen wellness, Herbalife rolls out Bioniq GO

Herbalife has launched Bioniq GO in the U.S., a personalized micronutrient supplement based on digital wellness assessments, as part of its strategy to focus on next-generation wellness. This initiative follows Herbalife's acquisition of Bioniq and other investments in personalized nutrition and healthspan companies. The …

CF Industries, Nutrien and Mosaic: best fertilizer stocks rated after earnings

Ausnutria Board Sets August Meeting to Review Interim Results and Dividend

Nutrien Ltd (NTR) Earnings Forecast: Future EPS & Revenue Growth Estimates

Nutex Health (NUTX) Earnings Turnaround Leaves The Question Of Whether Shares Are Fully Valued

Is Herbalife (HLF) Undervalued Following Raised Sales Guidance And A Quarterly Loss?

Does Nutrien (TSX:NTR) Pairing Higher Potash Volumes With Buybacks Refine Its Core Investment Story?

Nutrien Ltd. recently announced stronger-than-expected second-quarter results for 2026, with increased sales and net income, alongside a quarterly dividend and a US$261 million share buyback. The company also raised its full-year 2026 potash volume guidance, which, combined with reliability-driven expectations for nitrogen and phosphate, …

Herbalife Ltd. Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Herbalife Ltd. reported a surprise loss of US$0.25 per share in its second-quarter results, despite revenue of US$1.3 billion, which was in line with analyst expectations. Following this report, analysts have become more bearish, cutting EPS estimates and reducing the consensus price target by …

Nutrien (TSX:NTR) Stock Stalls As Profit Rebounds Meet Debt Doubts

Nutrien Q2 Earnings Call Highlights

Key Points Interested in Nutrien Ltd.? Here are five stocks we like better. Nutrien delivered solid first-half results: Adjusted EBITDA rose 6% to $3.5 billion, supported by record potash volumes, proprietary-product margins and operational execution. The company raised its 2026 potash sales-volume outlook and …

Nutriband Inc (NTRB) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for Nutriband Inc (NTRB), indicating a current earnings forecast score of 8.00 and an average price target of $15.00 based on one analyst. The analyst recommends a "Buy" rating for NTRB, suggesting a potential upside of over 370%.

Nutex Health (NUTX) Stock Reprices Higher As Profit Surge Meets IDR Risk

Nutex Health (NUTX) stock has seen a significant reprice upwards following a surge in Q2 2026 net income to US$65.8m, reversing a previous loss and highlighting its unexpected profitability. While supporters point to growing hospital volumes and operational improvements, skeptics remain concerned about the …

Herbalife Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Herbalife Ltd. (NYSE: HLF) recently missed analyst earnings estimates, leading to a downgrade in future revenue expectations. Analysts have revised their forecasts, projecting a 3.4% annual revenue decline over the next five years, with EPS expected to grow at a much slower rate than …

Herbalife Q2 Earnings Call Highlights

Key Points Interested in Herbalife Ltd? Here are five stocks we like better. Herbalife delivered solid second-quarter growth: Net sales rose 5.4% year over year to $1.3 billion, while adjusted EBITDA reached $167 million. Growth was led by India, Asia Pacific, Latin America and …

Herbalife (NYSE:HLF) Releases Earnings Results, Misses Estimates By $0.03 EPS

Nutex outlines 3 hospital openings in H2 2026 while maintaining 3 to 5 openings per year

Earnings Call Insights: Nutex Health (NUTX) Q2 2026 MANAGEMENT VIEW * "It was an active quarter, marked by strong financial results, important reimbursement developments and continued progress on our growth pipeline" (Chairman of the Board & CEO Thomas Vo). * "On the vendor front, …

Nutrien Reports Second Quarter 2026 Results

Nutrien Ltd. announced its second-quarter 2026 results, reporting net earnings of $1.22 billion ($2.53 diluted net earnings per share). The company achieved record potash sales volumes and strong growth in proprietary products margins, leading to increased cash returns to shareholders and raised guidance for …